VATHLT8100 - The zero rate for free-of-charge medicines: Background
Pharmaceutical companies may provide medicines free of charge in certain circumstances. As well as during clinical trials, medicines may be provided through a variety of routes including:
- For continued treatment of patients who took part in a clinical trial;
- Through manufacturer-operated patient access arrangements (sometimes referred to as ‘early access’, ‘managed access’, or ‘compassionate use’)
- Under a UK Government scheme administered by the Medicines & Healthcare products Regulatory Agency called the “Early Access to Medicines Scheme”.
While no consideration is paid for the medicines donated in the schemes described above, they are ‘deemed supplies’ as set out in Schedule 4 of the Value Added Tax Act 1994, requiring output VAT to be accounted for on the value of the medicines supplied. That means VAT is incurred even when companies do not charge for the medicines. This is not specific to medicines, but is a feature of the VAT system; where a business gives away its assets, a VAT charge arises even when those assets are given away for free.
This zero rate, effective from 23 June 2026, removes that VAT charge from certain supplies.
This applies when the medicines are to be used:
- For NHS treatment (see VATHLT8200);
- For a clinical trial (see VATHLT8310);
- For the continued treatment (with the same medicine) of a patient after a clinical trial has ended (see VATHLT8320).